Report Overview
Report Summary
The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in these regions.
This research report categorizes the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market by top players/brands, region, type and end user. This report also studies the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
Market size by Product
Live Vaccines
Killed Vaccines
Market size by End User
Government Tender
Market Sales
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Product
1.4.2 Live Vaccines
1.4.3 Killed Vaccines
1.5 Market by End User
1.5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by End User
1.5.2 Government Tender
1.5.3 Market Sales
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size
2.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue 2017-2027
2.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales 2017-2027
2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Growth Rate by Regions
2.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Regions
2.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturers
3.1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturers
3.1.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturers
3.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers
3.2.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers (2017-2020)
3.2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Manufacturers (2017-2020)
3.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Manufacturers
3.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Product
4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Product
4.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Breakdown Data by End User
6 North America
6.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Countries
6.1.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Countries
6.1.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Product
6.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by End User
7 Europe
7.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Countries
7.1.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Countries
7.1.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Product
7.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Countries
8.1.1 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Countries
8.1.2 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Product
8.3 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by End User
9 Central & South America
9.1 Central & South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Countries
9.1.1 Central & South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Countries
9.1.2 Central & South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Product
9.3 Central & South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Countries
10.1.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Countries
10.1.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Product
10.3 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by End User
11 Company Profiles
11.1 CAHIC
11.1.1 CAHIC Company Details
11.1.2 Company Business Overview
11.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
11.1.5 CAHIC Recent Development
11.2 Merial
11.2.1 Merial Company Details
11.2.2 Company Business Overview
11.2.3 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
11.2.5 Merial Recent Development
11.3 MSD Animal Health
11.3.1 MSD Animal Health Company Details
11.3.2 Company Business Overview
11.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
11.3.5 MSD Animal Health Recent Development
11.4 Chopper Biology
11.4.1 Chopper Biology Company Details
11.4.2 Company Business Overview
11.4.3 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
11.4.5 Chopper Biology Recent Development
11.5 Ceva
11.5.1 Ceva Company Details
11.5.2 Company Business Overview
11.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
11.5.5 Ceva Recent Development
11.6 ChengDu Tecbond
11.6.1 ChengDu Tecbond Company Details
11.6.2 Company Business Overview
11.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.6.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
11.6.5 ChengDu Tecbond Recent Development
11.7 Veterinary
11.7.1 Veterinary Company Details
11.7.2 Company Business Overview
11.7.3 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
11.7.5 Veterinary Recent Development
11.8 Ringpu Biology
11.8.1 Ringpu Biology Company Details
11.8.2 Company Business Overview
11.8.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
11.8.5 Ringpu Biology Recent Development
11.9 Qilu Animal
11.9.1 Qilu Animal Company Details
11.9.2 Company Business Overview
11.9.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
11.9.5 Qilu Animal Recent Development
11.10 DHN
11.10.1 DHN Company Details
11.10.2 Company Business Overview
11.10.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.10.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
11.10.5 DHN Recent Development
11.11 CAVAC
11.12 Komipharm
11.13 Agrovet
11.14 Bioveta
11.15 Jinyu Bio-Technology
11.16 Institutul Pasteur
11.17 MVP
11.18 Tecon
11.19 Zoetis
12 Future Forecast
12.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Forecast by Regions
12.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Regions 2019-2025
12.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Forecast by Product
12.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Product 2019-2025
12.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Forecast by End User
12.4 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecast
12.5 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecast
12.6 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecast
12.7 Central & South America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecast
12.8 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer